These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12456380)

  • 1. A randomized controlled trial of intravenous montelukast in acute asthma.
    Camargo CA; Smithline HA; Malice MP; Green SA; Reiss TF
    Am J Respir Crit Care Med; 2003 Feb; 167(4):528-33. PubMed ID: 12456380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE; Malmström K; Nizankowska E; Dahlén B; Kuna P; Kowalski M; Lumry WR; Picado C; Stevenson DD; Bousquet J; Pauwels R; Holgate ST; Shahane A; Zhang J; Reiss TF; Szczeklik A
    Am J Respir Crit Care Med; 2002 Jan; 165(1):9-14. PubMed ID: 11779723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function.
    Barnes N; Wei LX; Reiss TF; Leff JA; Shingo S; Yu C; Edelman JM
    Respir Med; 2001 May; 95(5):379-86. PubMed ID: 11392579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.
    Leff JA; Busse WW; Pearlman D; Bronsky EA; Kemp J; Hendeles L; Dockhorn R; Kundu S; Zhang J; Seidenberg BC; Reiss TF
    N Engl J Med; 1998 Jul; 339(3):147-52. PubMed ID: 9664090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of montelukast in the treatment of cough variant asthma.
    Spector SL; Tan RA
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):232-6. PubMed ID: 15478381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS; van Adelsberg J; Philip G; Tilles SA; Busse W; Hendeles L; Loeys T; Dass SB; Reiss TF
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of oral montelukast added to standard therapy for acute asthma exacerbations in children aged 6 to 14 years.
    Nelson KA; Smith SR; Trinkaus K; Jaffe DM
    Pediatr Emerg Care; 2008 Jan; 24(1):21-7. PubMed ID: 18165796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
    Camargo CA; Gurner DM; Smithline HA; Chapela R; Fabbri LM; Green SA; Malice MP; Legrand C; Dass SB; Knorr BA; Reiss TF
    J Allergy Clin Immunol; 2010 Feb; 125(2):374-80. PubMed ID: 20159247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma.
    Currie GP; Lee DK; Haggart K; Bates CE; Lipworth BJ
    Am J Respir Crit Care Med; 2003 May; 167(9):1232-8. PubMed ID: 12456382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Montelukast improves air trapping, not airway remodeling, in patients with moderate-to-severe asthma: a pilot study.
    Gao JM; Cai F; Peng M; Ma Y; Wang B
    Chin Med J (Engl); 2013 Jun; 126(12):2229-34. PubMed ID: 23786930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity.
    Busse WW; Casale TB; Dykewicz MS; Meltzer EO; Bird SR; Hustad CM; Grant E; Zeldin RK; Edelman JM
    Ann Allergy Asthma Immunol; 2006 Jan; 96(1):60-8. PubMed ID: 16440534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%.
    Becker A; Swern A; Tozzi CA; Yu Q; Reiss T; Knorr B
    Curr Med Res Opin; 2004 Oct; 20(10):1651-9. PubMed ID: 15462699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of addition of single dose of oral montelukast to standard treatment in acute moderate to severe asthma in children between 5 and 15 years of age: a randomised, double-blind, placebo controlled trial.
    Todi VK; Lodha R; Kabra SK
    Arch Dis Child; 2010 Jul; 95(7):540-3. PubMed ID: 20522464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study.
    Dupont L; Potvin E; Korn D; Lachman A; Dramaix M; Gusman J; Peché R;
    Curr Med Res Opin; 2005 Jun; 21(6):863-9. PubMed ID: 15969886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study.
    Ilowite J; Webb R; Friedman B; Kerwin E; Bird SR; Hustad CM; Edelman JM
    Ann Allergy Asthma Immunol; 2004 Jun; 92(6):641-8. PubMed ID: 15237766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids.
    Phipatanakul W; Greene C; Downes SJ; Cronin B; Eller TJ; Schneider LC; Irani AM
    Ann Allergy Asthma Immunol; 2003 Jul; 91(1):49-54. PubMed ID: 12877449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma.
    Jayaram L; Duong M; Pizzichini MM; Pizzichini E; Kamada D; Efthimiadis A; Hargreave FE
    Eur Respir J; 2005 Jan; 25(1):41-6. PubMed ID: 15640321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.
    Robinson DS; Campbell D; Barnes PJ
    Lancet; 2001 Jun; 357(9273):2007-11. PubMed ID: 11438132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial).
    Bjermer L; Bisgaard H; Bousquet J; Fabbri LM; Greening A; Haahtela T; Holgate ST; Picado C; Leff JA
    Respir Med; 2000 Jun; 94(6):612-21. PubMed ID: 10921768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J; Guerra F; Cuevas F; Gutierrez JP; Soto-Ramos M; Anderton S; Mechali D; Chan R; Pedersen S
    Clin Ther; 2008 Aug; 30(8):1492-504. PubMed ID: 18803991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.